#1292ef

Qilu Pharmaceuticals

#f9f9f9

Shuyong Zhao

Hao Liu

Yingying Yan

Shansong Zheng

Christine Yu

Lily Cheng

Daqing Sun

Amanda Qiao Jiang

Peng (gavin) Wang

Home
About Us
About Us
Overview
Our Vision
Honors and Milestones
Global Footprints
?????
????
????
????
???????
400-635-9960
R & D
R & D
Our Capabilities
Partnerships
?????
????
????
????
???????
400-635-9960
Products
Products
Finished Formulation
APIs
Therapeutic Focus
?????
????
????
????
???????
400-635-9960
Manufacturing
Manufacturing
Quality Policy
Sites
API
Finished Products
Biosimilars
Quality
?????
????
????
????
???????
400-635-9960
News
News
Company News
?????
????
????
????
???????
400-635-9960
Contact Us
Search
?????????
Caring Through Science & Technology
MORE +
scroll down
PRODUCT CENTER
To date, Qilu has launched over 300 products with over 50 products ?First-to- launch? in China. The company has also fostered a robust pipeline including over 200 generic products, over 30 biosimilars and over 90 innovative products.
FINISHED DOSAGE FORMS
Leading injectable and solid dose manufacturer with significant in-house development and manufacturing capabilities.
Click to view +
ACTIVE PHARMACEUTICAL INGREDIENTS
Equipped with large-scale manufacturing facilities for the production of chemically synthesized, lyophilized, sterile, crystallized and fermented APIs.
Click to view +
ABOUT US
Originated from QILU, Universal love to the WORLD
Qilu Pharmaceutical is one of the leading vertically integrated pharmaceutical companies in China focusing on the development, manufacturing and marketing of active pharmaceutical ingredients (APIs) & finished formulations. Qilu currently has 13 subsidiaries, 11 manufacturing sites and over 36,000 employees worldwide, 70% of whom are with bachelor?s degree or above. It ranks No.10 in Chinese pharmaceutical industry by sales revenue in 2021. Dedicated to offering more affordable medicines to the world and improving people's well-being, Qilu has exported its products to over 101 countries.
Qilu Pharmaceutical has always maintained an innovative development strategy guided by the market demand and is achieving its organic growth strategy utilizing a strong pool of over 3,500 scientists spread across 5 R&D platforms based in the US (Seattle WA, Boston MA, San Francisco CA) and China (Shanghai, Jinan). To date, Qilu has launched over 200 products with over 50 products ?First to launch? in China and 3 products ?D181 launch?in US. The company has also a robust pipeline, including over 200 generic products, over 30 biosimilar products and over 90 innovative products.
EXPLORE MORE >>
11
Domestic Manufacturing Sites
10 TOP
Chinese Pharma. & Industrial Enterprise
36000 +
Employees
300 +
Marketed Products
R & D
Our Capabilities
Focusing on the research and development of generic and innovative drugs, Qilu Pharmaceutical has formed a complete innovative development system covering early stage discovery...
Partnerships
At Qilu, we believe communication and collaboration are key to success and we are always open for different cooperative models and opportunities, especially license and co-development opportunities in the following areas:

Qilu pharmaceutical co.,ltd. | Caring through Science & Technology Awards and Honors Qilu pharmaceutical co.,ltd.-Located in Jinan, Qilu Pharmaceutical is one of the leading pharmaceutical companies in China. It focuses on developing.